230 related articles for article (PubMed ID: 26824323)
1. Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism.
Itkonen HM; Gorad SS; Duveau DY; Martin SE; Barkovskaya A; Bathen TF; Moestue SA; Mills IG
Oncotarget; 2016 Mar; 7(11):12464-76. PubMed ID: 26824323
[TBL] [Abstract][Full Text] [Related]
2. O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer cells.
Itkonen HM; Minner S; Guldvik IJ; Sandmann MJ; Tsourlakis MC; Berge V; Svindland A; Schlomm T; Mills IG
Cancer Res; 2013 Aug; 73(16):5277-87. PubMed ID: 23720054
[TBL] [Abstract][Full Text] [Related]
3. High OGT activity is essential for MYC-driven proliferation of prostate cancer cells.
Itkonen HM; Urbanucci A; Martin SE; Khan A; Mathelier A; Thiede B; Walker S; Mills IG
Theranostics; 2019; 9(8):2183-2197. PubMed ID: 31149037
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of O-GlcNAc Transferase Renders Prostate Cancer Cells Dependent on CDK9.
Itkonen HM; Poulose N; Steele RE; Martin SES; Levine ZG; Duveau DY; Carelli R; Singh R; Urbanucci A; Loda M; Thomas CJ; Mills IG; Walker S
Mol Cancer Res; 2020 Oct; 18(10):1512-1521. PubMed ID: 32611550
[TBL] [Abstract][Full Text] [Related]
5. Nutrient sensor O-GlcNAc transferase regulates breast cancer tumorigenesis through targeting of the oncogenic transcription factor FoxM1.
Caldwell SA; Jackson SR; Shahriari KS; Lynch TP; Sethi G; Walker S; Vosseller K; Reginato MJ
Oncogene; 2010 May; 29(19):2831-42. PubMed ID: 20190804
[TBL] [Abstract][Full Text] [Related]
6. Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis.
Lynch TP; Ferrer CM; Jackson SR; Shahriari KS; Vosseller K; Reginato MJ
J Biol Chem; 2012 Mar; 287(14):11070-81. PubMed ID: 22275356
[TBL] [Abstract][Full Text] [Related]
7. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of O-Linked N-Acetylglucosamine Transferase Reduces Replication of Herpes Simplex Virus and Human Cytomegalovirus.
Angelova M; Ortiz-Meoz RF; Walker S; Knipe DM
J Virol; 2015 Aug; 89(16):8474-83. PubMed ID: 26041297
[TBL] [Abstract][Full Text] [Related]
9. O-GlcNAc transferase couples MRE11 to transcriptionally active chromatin to suppress DNA damage.
Gondane A; Girmay S; Helevä A; Pallasaho S; Loda M; Itkonen HM
J Biomed Sci; 2022 Feb; 29(1):13. PubMed ID: 35164752
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of O-GlcNAc by prostate cancer cells is significantly associated with poor prognosis of patients.
Kamigaito T; Okaneya T; Kawakubo M; Shimojo H; Nishizawa O; Nakayama J
Prostate Cancer Prostatic Dis; 2014 Mar; 17(1):18-22. PubMed ID: 24366413
[TBL] [Abstract][Full Text] [Related]
11. O-GlcNAc transferase maintains metabolic homeostasis in response to CDK9 inhibition.
Gondane A; Poulose N; Walker S; Mills IG; Itkonen HM
Glycobiology; 2022 Aug; 32(9):751-759. PubMed ID: 35708495
[TBL] [Abstract][Full Text] [Related]
12. Monitoring of Intracellular Tau Aggregation Regulated by OGA/OGT Inhibitors.
Lim S; Haque MM; Nam G; Ryoo N; Rhim H; Kim YK
Int J Mol Sci; 2015 Aug; 16(9):20212-24. PubMed ID: 26343633
[TBL] [Abstract][Full Text] [Related]
13. O-GlcNAc Transferase Regulates Angiogenesis in Idiopathic Pulmonary Arterial Hypertension.
Barnes JW; Tian L; Krick S; Helton ES; Denson RS; Comhair SAA; Dweik RA
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847126
[TBL] [Abstract][Full Text] [Related]
14. Targeted covalent inhibition of O-GlcNAc transferase in cells.
Worth M; Hu CW; Li H; Fan D; Estevez A; Zhu D; Wang A; Jiang J
Chem Commun (Camb); 2019 Oct; 55(88):13291-13294. PubMed ID: 31626249
[TBL] [Abstract][Full Text] [Related]
15. Alloxan is an inhibitor of the enzyme O-linked N-acetylglucosamine transferase.
Konrad RJ; Zhang F; Hale JE; Knierman MD; Becker GW; Kudlow JE
Biochem Biophys Res Commun; 2002 Apr; 293(1):207-12. PubMed ID: 12054585
[TBL] [Abstract][Full Text] [Related]
16. Structure-Based Evolution of Low Nanomolar O-GlcNAc Transferase Inhibitors.
Martin SES; Tan ZW; Itkonen HM; Duveau DY; Paulo JA; Janetzko J; Boutz PL; Törk L; Moss FA; Thomas CJ; Gygi SP; Lazarus MB; Walker S
J Am Chem Soc; 2018 Oct; 140(42):13542-13545. PubMed ID: 30285435
[TBL] [Abstract][Full Text] [Related]
17. O-GlcNAc Transferase: Structural Characteristics, Catalytic Mechanism and Small-Molecule Inhibitors.
Ju Kim E
Chembiochem; 2020 Nov; 21(21):3026-3035. PubMed ID: 32406185
[TBL] [Abstract][Full Text] [Related]
18. A small molecule that inhibits OGT activity in cells.
Ortiz-Meoz RF; Jiang J; Lazarus MB; Orman M; Janetzko J; Fan C; Duveau DY; Tan ZW; Thomas CJ; Walker S
ACS Chem Biol; 2015 Jun; 10(6):1392-7. PubMed ID: 25751766
[TBL] [Abstract][Full Text] [Related]
19. VPRBP Functions Downstream of the Androgen Receptor and OGT to Restrict p53 Activation in Prostate Cancer.
Poulose N; Forsythe N; Polonski A; Gregg G; Maguire S; Fuchs M; Minner S; Sauter G; McDade SS; Mills IG
Mol Cancer Res; 2022 Jul; 20(7):1047-1060. PubMed ID: 35348747
[TBL] [Abstract][Full Text] [Related]
20. Label-free electrochemical biosensing of small-molecule inhibition on O-GlcNAc glycosylation.
Yang Y; Gu Y; Wan B; Ren X; Guo LH
Biosens Bioelectron; 2017 Sep; 95():94-99. PubMed ID: 28427012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
